HOME > BUSINESS > Mangalam Drugs Vapi plant starts trial operations

Mangalam Drugs Vapi plant starts trial operations

mangalamdrugsMangalam Drugs & Organics said the expansion works of its Plant on Unit-2 situated at Vapi have been successfully completed.

The company commenced the trial operations at this newly expanded plant on 22nd August.

The plant will produce the active pharmaceutical ingredients (API) for Malaria and anti-retroviral drugs.

The Company will be filing Drug Master File (DMF) for all its product with World Health Organization Geneva, it said.

DMFs are used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs to regulatory agencies.

It also plans to file DMF’s of certain API’s with United States Food & Drug Administration in the due course of time.

The total cost of the expansion was approximately Rs 30 Crore which was completed in time.

Mangalam Drugs & Organics Limited commenced in 1977 its manufacturing of Active Pharmaceutical Ingredients APIs, Intermediates at VAPI – Gujarat. It has a multi-product manufacturing facility on two locations, and an in-house R&D.

Follow ULTRA.news
SpiceJet starts flights to Patna from Bangalore, Hyderabad, Mumbai & Kolkata SpiceJet, the airline that offers one of the most cost-effective set of fares in India, said it was starting daily flights to Patna from several cities in India, including Mumbai, Hyderabad, Bangalore and Kolkata.On Tuesday, the Bangalore flight will be replaced by a Chenna...
We expected better numbers: Vishal Sikka of Infosys Infosys Chief Executive Officer Vishal Sikka said the company's performance in the January-March period was below his expectations for various reasons."It is a challenging performance," Sikka said in a post-result press conference. "We were expecting a higher number," sai...
NTPC starts 660 MW Solapur Super Thermal Power Project in Maharashtra One of NTPC's thermal plantsNTPC Ltd, India's largest power producer, has taken its total installed production capacity beyond the 51,000 MW mark with the addition of the 660 MW Solapur Super Thermal Power Project in Maharashtra.The total capacity of the NTPC Group has b...
Tech Mahindra opens robotics, AI and digital services center in Dublin IT services provider Tech Mahindra opened a new facility in Dublin, Ireland to focus on emerging technologies such as Robotics and Automation, Business Analytics, Cloud Infrastructure and Digital Services.The new centre would employ around 150 engineers over the next three ye...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been termi...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta ta...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
Apollo Tyres to invest Rs 525 cr in Andhra Pradesh Apollo Tyres today signed an agreement with the Andhra Pradesh government to set up a manufacturing facility in the state.“As per the Memorandum of Understanding, the company will invest approx. Rs 525 cr for setting up this facility in Andhra Pradesh bordering the south-east...
Rajesh Exports starts second phase of retail expansion with Bangalore Gold Jewellery exporter, Rajesh Exports Ltd said it launched its 81st retail showroom under it's brand name ´Shubh Jewellers´ at Bangalore.“With this launch the company has launched it's second phase of retail expansion. The company in the second phase of retail expansion has...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being de...
Aarti Industries to return Rs 96 cr to shareholders via buyback Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.The company´s Board of Directors approved the equity shares -- representing up to 1.44% of the company's base."The public announcement sett...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in t...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supp...
Lupin licenses taste-masking technology from Monosol for paediatric tablets Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products.Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery ...
Cadila to launch immunosuppressant drug in India Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body's immune system in India.The drug named Grafalon...
Thomas Cook tries the ‘mini’ approach to keep costs low in Tier 3 cities Thomas Cook, one of leading travel consultants, said it has launched an outlet in Rudrapur city in Uttarkhand under its new Mini format.The Rudrapur outlet has been designed optimising space and will be manned by a two member team, equipped with technology via mobile devices ...
Almebic Pharmaceuticals receives inspection report from USFDA Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat.The FDA has the authority to inspect any establishment in whi...
Hexaware Technologies opens new operations center in Bucharest Hexaware Technologies Limited, a BPO and Digital services provider, said it has expanded its delivery presence in the European region by opening of its latest Global Delivery Centre in Bucharest, Romania.The Bucharest Global Delivery centre is situated in a prime location and...
Shilpa Medicare receives USFDA approval for generic bone marrow drug Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection.Azacitidine is used to treat myelodysplastic syndrome - a group of conditions in which the bone marrow produces blood cells that are misshapen and ...
FDA observations ‘primarily procedural’ – USFDA issued four observations about Cipla's manufacturing facilities in Goa after conducting an audit, the company said. Cipla has three facilities in Goa."The observations were primarily procedural in nature and the company has already responded to these observations," said...
Lupin receives FDA approval for generic Namenda XR dementia capsules Pharma Major Lupin Ltd said it received final approval from United States Food and Drug Administration for selling Memantine Hydrochloride extended-release capsules, a generic version of Allergan’s Namenda XR capsules.Namenda XR extended-release capsules are approved by the...
Kilitch Drugs to set up plant in Ethiopia Kilitch Drugs (India) Ltd said its unit Kilitch Estro Biotech Plc acquired land for the installation of a pharma plant in Ethiopia.4317.5 sq. mtrs of land was allotted at Oromia special zone by the Bureau of Rural Land and Environmental Protection, Federal Democratic Republic...
Suven Life Sciences gets two product patents in India and Japan Drug manufacturer Suven Life Sciences Ltd said it got two product patents in India and Japan for to a new compound for the treatment of disorders associated with Neurodegenerative diseases.The patents are valid through 2026-2032.The granted claims include a class of selec...